Eikon Therapeutics News and Activities

Eikon Therapeutics is one of the...

• TOB Iconic 10,000;
• Unicorn.

Acquisition, funding and merger involving Eikon Therapeutics.

• Eikon Therapeutics has just announced a $351 Million fundraising (posted on February 27 2025).

View the org chart displaying its 27 main executives

Most searched biographies at Eikon Therapeutics

• Roger Perlmutter, Chief Executive Officer and Director
• Kenneth Frazier, Director
• Fatima Francisco, Director

Popular executive movements at Eikon Therapeutics

• Fatima Francisco has joined the company as Director  (posted on June 8 2026).
• David Meline has joined the company as Independent Director  (posted on December 3 2025).

Create your alert
to follow the executive moves at Eikon Therapeutics.

Eikon Therapeutics has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Eikon Therapeutics

• Eikontx
• Eikontx

Social media about Eikon Therapeutics

• Eikon Therapeutics on Wikipedia, Google News & Yahoo Finance
• Eikon Therapeutics on LinkedIn, X (Twitter) & YouTube